ArticlePharmaceutical research2025
Development and optimisation of Polyelectrolyte Complex Nanoparticles Loaded with Sorafenib by Central Composite Design (CCD): In Vitro and In Vivo Studies for the Treatment of Triple Negative Breast Cancer.
Sangita A Kale et al.PubMed ↗Publisher ↗
No numbers read from the abstract.